Tse W. Chang
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
First-in-Human Study of a Long-Acting GLP-1 Receptor Agonist (TE-8105) in Overweight or Obese Adults Without Type 2 Diabetes Mellitus.
Journal: Journal of clinical pharmacology
Published: March 11, 2026
Optimized sublingual delivery of dual fatty acid-conjugated GLP-1 receptor agonist TE-8105 produces durable efficacy in diabetic mice.
Journal: International journal of pharmaceutics
Published: December 24, 2025
2FA-Platform Generates Dual Fatty Acid-Conjugated GLP-1 Receptor Agonist TE-8105 with Enhanced Diabetes, Obesity, and NASH Efficacy Compared to Semaglutide.
Journal: Journal of medicinal chemistry
Published: March 05, 2025
An Antibody-Drug Conjugate for Multiple Myeloma Prepared by Multi-Arm Linkers.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 18, 2023
Bispecific Antibody Binding To RANKL and Osteonectin with Enhanced Localization to the Bone.
Journal: Molecular pharmaceutics
Published: September 29, 2017
Treating IgE-mediated diseases via targeting IgE-expressing B cells using an anti-CεmX antibody.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: April 17, 2016
Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps.
Journal: The Journal of allergy and clinical immunology
Published: September 25, 2015
Structural and Physical Basis for Anti-IgE Therapy.
Journal: Scientific reports
Published: March 26, 2015
Changing patterns of antigen exposure and their impact on the prevalence of allergy.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: November 03, 2014
Last Updated: 09/26/2026